New Avenues of Exploration for Erythropoietin
Top Cited Papers
- 5 January 2005
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 293 (1) , 90-5
- https://doi.org/10.1001/jama.293.1.90
Abstract
Discovery that the hormone erythropoietin (EPO) and its receptor play a significant biological role in tissues outside of the hematopoietic system has fueled significant interest in EPO as a novel cytoprotective agent in both neuronal and vascular systems. Erythropoietin is now considered to have applicability in a variety of disorders that include cerebral ischemia, myocardial infarction, and chronic congestive heart failure. Erythropoietin modulates a broad array of cellular processes that include progenitor stem cell development, cellular integrity, and angiogenesis. As a result, cellular protection by EPO is robust and EPO inhibits the apoptotic mechanisms of injury, including the preservation of cellular membrane asymmetry to prevent inflammation. As the investigation into clinical applications for EPO that maximize efficacy and minimize toxicity progresses, a deeper appreciation for the novel roles that EPO plays in the brain and heart and throughout the entire body should be acquired.Keywords
This publication has 49 references indexed in Scilit:
- Pure Red-Cell Aplasia and Epoetin TherapyNew England Journal of Medicine, 2004
- The NAD+Precursor Nicotinamide Governs Neuronal Survival During Oxidative Stress Through Protein Kinase B Coupled to FOXO3a and Mitochondrial Membrane PotentialJournal of Cerebral Blood Flow & Metabolism, 2004
- AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9Experimental Cell Research, 2004
- Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findingsNeurosurgical Review, 2004
- Central Nervous System Frontiers for the Use of ErythropoietinClinical Infectious Diseases, 2003
- Critical Role for Akt1 in the Modulation of Apoptotic Phosphatidylserine Exposure and Microglial ActivationMolecular Pharmacology, 2003
- Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cellsOncogene, 2002
- Increased Cerebral Infarct Volumes in Polyglobulic Mice Overexpressing ErythropoietinJournal of Cerebral Blood Flow & Metabolism, 2001
- Proteasomes Regulate the Duration of Erythropoietin Receptor Activation by Controlling Down-regulation of Cell Surface ReceptorsJournal of Biological Chemistry, 2000
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992